Abiopharma

News list

Director BENDHEIM JACK 🔴 sold 213 shares of PHIBRO ANIMAL HEALTH CORP (PAHC) at $40.16 Transaction Date: Jan 09, 2026 | Filing ID: 003467

Full text

News bot Jan. 29, 2026, 6:28 p.m.
🔍 BENDHEIM JACK (Director)

Company: PHIBRO ANIMAL HEALTH CORP (PAHC)

Report Date: 2026-01-09
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares sold: 213
- Total shares held: 16,840
Detailed Transactions and Holdings:
- Sold 213 shares of Class A Common Stock at $40.16 per share (Direct)
  Date: 2026-01-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 38,659.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-01-09 | Code: H | shares_owned_after: 16,840.00 | Footnotes: F3
Footnotes:
- F1: The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC ("BFI") on May 30, 2025.
- F2: The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the "Issuer"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- F3: The reported securities are directly held by Jack Bendheim.